v3.26.1
Statements of Cash Flows - USD ($)
 12 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Cash flows from operating activities:    
Net loss $ (8,772,382) $ (4,514,853)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 110,740 50,740
Interest expense - debt discount 9,286
Stock-based compensation to employees, directors and consultants 707,527 325,108
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (825,089) (149,525)
Accounts payable and accrued liabilities 711,391 (2,288,942)
Net cash used in operating activities (8,067,813) (6,568,186)
Cash flows from investing activities:    
Purchase of equipment (300,000)
Net cash used in investing activities (300,000)
Cash flows from financing activities:    
Net proceeds from the issuance of common stock 794,844 2,704,052
Proceeds from stock option exercise 600
Net proceeds from the issuance of preferred stock 4,035,000 7,736,144
Net cash provided by financing activities 4,829,844 10,440,796
Net (decrease) increase in cash (3,237,969) 3,572,610
Cash at beginning of period 3,948,658 376,048
Cash at end of period 710,689 3,948,658
Non-cash financing activities:    
Conversion of Series A convertible preferred stock to common stock 7,120,133
Conversion of Series B convertible preferred stock to common stock 2,100,000
Conversion of Series C convertible preferred stock to common stock 5,757,176 239,712
Fair value of warrants issued in connection with Series A convertible preferred stock 1,635,489
Preferred stock dividends 117,022
Conversion of note payable and accrued interest into Series A convertible preferred stock 311,356
Exchange of Series A convertible preferred stock into Series C convertible preferred stock 977,511
Fair value of warrants issued with preferred stock $ 577,073